NAB2
NGFI-A-binding protein 2
Also known as: MADER, NAB2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15742
- Gene
- NAB2
- Ensembl
- ENSG00000166886
- Chromosome
- 12
- Canonical length
- 525 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
This gene encodes a member of the family of NGFI-A binding (NAB) proteins, which function in the nucleus to repress transcription induced by some members of the EGR (early growth response) family of transactivators. NAB proteins can homo- or hetero-multimerize with other EGR or NAB proteins through a conserved N-terminal domain, and repress transcription through two partially redundant C-terminal domains. Transcriptional repression by the encoded protein is mediated in part by interactions with the nucleosome remodeling and deactylase (NuRD) complex. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
525 residues, UniProt reviewed canonical sequence.
>Q15742|NAB2
1 MHRAPSPTAE QPPGGGDSAR RTLQPRLKPS ARAMALPRTL GELQLYRVLQ RANLLSYYET
61 FIQQGGDDVQ QLCEAGEEEF LEIMALVGMA TKPLHVRRLQ KALREWATNP GLFSQPVPAV
121 PVSSIPLFKI SETAGTRKGS MSNGHGSPGE KAGSARSFSP KSPLELGEKL SPLPGGPGAG
181 DPRIWPGRST PESDVGAGGE EEAGSPPFSP PAGGGVPEGT GAGGLAAGGT GGGPDRLEPE
241 MVRMVVESVE RIFRSFPRGD AGEVTSLLKL NKKLARSVGH IFEMDDNDSQ KEEEIRKYSI
301 IYGRFDSKRR EGKQLSLHEL TINEAAAQFC MRDNTLLLRR VELFSLSRQV ARESTYLSSL
361 KGSRLHPEEL GGPPLKKLKQ EVGEQSHPEI QQPPPGPESY VPPYRPSLEE DSASLSGESL
421 DGHLQAVGSC PRLTPPPADL PLALPAHGLW SRHILQQTLM DEGLRLARLV SHDRVGRLSP
481 CVPAKPPLAE FEEGLLDRCP APGPHPALVE GRRSSVKVEA EASRQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 58 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 58 nTPM
- ovary: 53 nTPM
- blood vessel: 40 nTPM
- cervix: 38 nTPM
- pituitary gland: 36 nTPM
- endometrium: 35 nTPM
Single-cell type
- syncytiotrophoblasts: 62 nCPM
- decidual stromal cells: 50 nCPM
- breast secretory cells: 37 nCPM
- pituicytes/fscs: 37 nCPM
- epididymal basal cells: 34 nCPM
- epididymal principal cells: 29 nCPM
Immune cell
- non-classical monocyte: 3 nTPM
- intermediate monocyte: 2.7 nTPM
- naive B-cell: 2.3 nTPM
- naive CD8 T-cell: 1.2 nTPM
- classical monocyte: 1.1 nTPM
- naive CD4 T-cell: 1.1 nTPM
Brain region
- cerebellum: 31 nTPM
- cerebral cortex: 31 nTPM
- hippocampal formation: 28 nTPM
- basal ganglia: 24 nTPM
- hypothalamus: 21 nTPM
- amygdala: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 3.01
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endochondral ossification
- myelination
- negative regulation of transcription by RNA polymerase III
- regulation of DNA-templated transcription
- regulation of epidermis development
- Schwann cell differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NAB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAB2 as an antibody target. Whether an autoantibody or antibody against NAB2 could matter depends on whether native NAB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NAB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...